Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://donnazdxr473216.loginblogin.com/46987813/trelaglutide-exploring-a-new-therapy-for-chronic-diseases